Protagenic Therapeutics, Inc.\new
Pharmaceutical company · New York, United States · OTC: PTIX
Protagenic Therapeutics, Inc.\new is a pharmaceutical company headquartered in New York, United States. Its shares trade on OTC under the ticker PTIX. It has reported private securities offerings to the US SEC, most recently $670,000 sold in a notice filed in 2019.
Protagenic Therapeutics, Inc.\new at a glance
What does Protagenic Therapeutics, Inc.\new do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $670,000 sold (2019).
Frequently asked questions about Protagenic Therapeutics, Inc.\new
Where is Protagenic Therapeutics, Inc.\new headquartered?
Protagenic Therapeutics, Inc.\new is headquartered in New York, United States.
What does Protagenic Therapeutics, Inc.\new do?
Protagenic Therapeutics, Inc.\new is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Protagenic Therapeutics, Inc.\new a public company?
Yes. Protagenic Therapeutics, Inc.\new trades on OTC under the ticker PTIX.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences